June 4 2020
Early Scientific Intelligence pipeline gives 360 degree view of “novelty” in diabetes and obesity
We hear a lot these days about evidence-based decision making. Particularly in the current climate, it’s critical that governments, businesses, health organisations and individuals are guided by facts and evidence, not fiction and hearsay. But what do we really mean by evidence-based decision making? Ideally, before making any decision, you want to be able to gather all relevant information, synthesized from different relevant sources. This approach allows you to see the overall picture, drill down to details, understand and weigh up the evidence and therefore make the best decision possible.
Creating a hub of evidence
Getting a comprehensive view of the whole picture is something Linguamatics pharma and healthcare customers need for their decision making in many different arenas - and that often means being able to integrate information from unstructured textual data streams together with data from structured sources. Capturing and integrating the information from a range of document sources can build a landscape of knowledge, a “hub” of evidence. Evidence hubs can be developed for discovery, development, regulatory affairs, safety, patient risk; with input data sources and output dashboards or alerts tailored as needed.
Novo Nordisk are using this integrated approach for an “Early Scientific Intelligence” evidence hub. Sten Christensen & Brian Schurmann (Novo Nordisk) presented on this innovative project at our virtual NLP summit on Thursday 4th June 2020.